COVID–19 pandemic fails to deter osteoporosis treatment initiation: New study reveals steady rates
Whether patients with newly diagnosed osteoporosis received delayed pharmacologic treatment due to the COVID–19 pandemic.
Whether patients with newly diagnosed osteoporosis received delayed pharmacologic treatment due to the COVID–19 pandemic.
Based on recent headline ratings, % of this readership currently trusts the local media, which has an average score of % regionally and is currently trending .